CVS Health Corporation (CVS) income statement
NYSE · Healthcare · Medical - Healthcare Plans · 259,500 employees · CEO J. David Joyner
- Price
- $90.25 -0.09%
- Market cap
- $115B
- Enterprise value
- $180B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-04 EPS est. $1.65
CVS Health Corporation (CVS) reported revenue of $106B for Q2 '26 (+7.3% year on year), operating income of $4.7B (4.4% of revenue) and net income of $3B. Over the last four quarters revenue was $415B.
Income statement
| Income statement | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $89.8B | $93.8B | $88.4B | $91.2B | $95.4B | $97.7B | $94.6B | $98.9B | $103B | $106B | $100B | $106B | |
| Cost of revenue | $76.2B | $79.9B | $75.9B | $77.9B | $82.9B | $84.8B | $80.2B | $85.3B | $89.1B | $92.1B | $84.8B | $90.3B | |
| Gross profit | $13.6B | $13.9B | $12.6B | $13.4B | $12.6B | $12.9B | $14.4B | $13.6B | $13.8B | $13.6B | $15.6B | $15.7B | |
| Other operating expenses | $9.89B | $10.5B | $10.3B | $10.3B | $11.7B | $10.5B | $11B | $11.2B | $17B | $11.5B | $10.9B | $11B | |
| Operating expenses | $9.89B | $10.5B | $10.3B | $10.3B | $11.7B | $10.5B | $11B | $11.2B | $17B | $11.5B | $10.9B | $11B | |
| Operating income | $3.69B | $3.37B | $2.27B | $3.05B | $832M | $2.37B | $3.37B | $2.38B | -$3.21B | $2.11B | $4.68B | $4.7B | |
| Interest expense | $693M | $690M | $716M | $732M | $752M | $758M | $785M | $763M | $784M | $787M | $774M | $757M | |
| Other non-operating income (gains on investments, FX ...) | -$22M | -$22M | -$25M | -$24M | -$25M | -$512M | -$28M | -$29M | -$509M | -$29M | -$32M | -$31M | |
| Total non-operating income | -$671M | -$668M | -$691M | -$708M | -$727M | -$242M | -$757M | -$734M | -$275M | -$758M | -$742M | -$726M | |
| Income before tax | $3.02B | $2.71B | $1.58B | $2.34B | $105M | $2.13B | $2.62B | $1.65B | -$3.48B | $1.35B | $3.94B | $3.98B | |
| Income tax | $754M | $658M | $456M | $569M | $34M | $503M | $835M | $634M | $508M | -$1.57B | $995M | $982M | |
| Net income | $2.26B | $2.05B | $1.11B | $1.77B | $87M | $1.64B | $1.78B | $1.02B | -$3.98B | $2.94B | $2.94B | $3B | |
| EPS (basic) | $1.76 | $1.59 | $0.88 | $1.41 | $0.07 | $1.31 | $1.41 | $0.81 | -$3.13 | $2.32 | $2.31 | $2.33 | |
| EPS (diluted) | $1.75 | $1.59 | $0.88 | $1.41 | $0.07 | $1.30 | $1.41 | $0.80 | -$3.13 | $2.30 | $2.30 | $2.31 | |
| Shares (basic, weighted) | 1.29B | 1.29B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.27B | 1.27B | 1.27B | 1.28B | |
| Shares (diluted, weighted) | 1.29B | 1.29B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.27B | 1.28B | 1.28B | 1.28B | |
| Depreciation & amortization | $1.13B | $1.13B | $1.14B | $1.15B | $1.16B | $1.15B | $1.15B | $1.17B | $1.13B | $1.15B | $1.12B | $1.13B | |
| EBITDA | $4.84B | $4.53B | $3.43B | $4.22B | $2.02B | $4.03B | $4.56B | $3.58B | -$1.56B | $3.29B | $5.83B | $5.86B |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $178B | $185B | $195B | $257B | $269B | $292B | $322B | $358B | $373B | $402B | |
| Cost of revenue | $149B | $156B | $163B | $211B | $220B | $240B | $268B | $303B | $321B | $347B | |
| Gross profit | $28.8B | $28.5B | $31.5B | $45.5B | $49B | $52.1B | $54.5B | $54.4B | $51.4B | $55.4B | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $989M | $0 | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $40.2B | $0 | |
| Other operating expenses | $18.4B | $19B | $27.5B | $33.5B | $35.1B | $38.8B | $46.5B | $40.7B | $1.66B | $45B | |
| Operating expenses | $18.4B | $19B | $27.5B | $33.5B | $35.1B | $38.8B | $46.5B | $40.7B | $42.9B | $45B | |
| Operating income | $10.4B | $9.54B | $4.02B | $12B | $13.9B | $13.3B | $7.95B | $13.7B | $8.52B | $10.4B | |
| Interest income | $20M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Interest expense | $1.08B | $1.06B | $2.62B | $3.04B | $2.91B | $2.5B | $2.29B | $2.66B | $2.96B | $3.12B | |
| Other non-operating income (gains on investments, FX ...) | $671M | $208M | -$4M | -$45M | $1.23B | $270M | -$169M | -$88M | -$590M | $5.13B | |
| Total non-operating income | -$1.75B | -$1.27B | -$2.62B | -$2.99B | -$4.14B | -$2.77B | -$2.12B | -$2.57B | -$2.37B | -$8.25B | |
| Income before tax | $8.64B | $8.27B | $1.41B | $9B | $9.77B | $10.5B | $5.84B | $11.2B | $6.15B | $2.14B | |
| Income tax | $3.32B | $1.64B | $2B | $2.37B | $2.57B | $2.55B | $1.51B | $2.81B | $1.56B | $408M | |
| Net income | $5.32B | $6.62B | -$594M | $6.63B | $7.18B | $8B | $4.31B | $8.34B | $4.61B | $1.77B | |
| EPS (basic) | $4.93 | $6.47 | -$0.57 | $5.10 | $5.48 | $6.00 | $3.29 | $6.49 | $3.66 | $1.40 | |
| EPS (diluted) | $4.90 | $6.44 | -$0.57 | $5.08 | $5.46 | $5.95 | $3.26 | $6.47 | $3.66 | $1.39 | |
| Shares (basic, weighted) | 1.07B | 1.02B | 1.04B | 1.3B | 1.31B | 1.32B | 1.31B | 1.29B | 1.26B | 1.27B | |
| Shares (diluted, weighted) | 1.08B | 1.02B | 1.04B | 1.31B | 1.31B | 1.33B | 1.32B | 1.29B | 1.26B | 1.27B | |
| Depreciation & amortization | $2.48B | $2.48B | $2.72B | $4.37B | $4.44B | $4.49B | $4.22B | $4.37B | $4.6B | $4.61B | |
| EBITDA | $12.2B | $11.8B | $6.74B | $16.4B | $17.1B | $17.5B | $12.3B | $18.2B | $13.7B | $9.86B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01